Clinical Usefulness of Monitoring Expression Levels of CCL24 (Eotaxin-2) mRNA on the Ocular Surface in Patients with Vernal Keratoconjunctivitis and Atopic Keratoconjunctivitis

Table 1

Subjects and their demographic data.

	Control	AKC/VKC	value
Number of subjects	12	18
Age (years); (mean ± SD)			0.272
Gender; (male : female)	10 : 2	14 : 4	0.709
Positive ratio of CCL24 (eotaxin-2) mRNA expression
Positive	8	17	0.046
Negative	4	1

AKC: atopic keratoconjunctivitis; VKC: vernal keratoconjunctivitis.
Negative: below the lowest level of detection limit of real-time reversed transcription polymerase chain reaction.